Haya Alzeer | Pharmacology | Research Excellence Award

Research Excellence Award

Haya Alzeer
Saudi Food and Drug Authority

 

Haya Alzeer
Researcher Haya Alzeer
Affiliation Saudi Food and Drug Authority
Country Saudi Arabia
Scopus ID 57202029321
Citations 44 by 4 docments
h-index 3
Subject Area Pharmacology
Event International Environmental Scientists Award
ORCID
0009-0001-2301-4793

Haya Alzeer recognizes scholarly achievement, scientific contribution, and professional dedication within the fields of pharmacology and public health research. Haya Alzeer, affiliated with the Saudi Food and Drug Authority, has contributed to scientific investigations associated with pharmacological sciences, healthcare evaluation, and evidence-based analytical approaches. Her academic profile reflects continued engagement with peer-reviewed scientific literature and international research indexing platforms.[1]

Abstract

This academic recognition article documents the scholarly profile and research-oriented achievements of Haya Alzeer in the domain of pharmacology and health sciences. Her contributions are associated with scientific evaluation methodologies, healthcare-related analytical studies, and participation in indexed academic publishing platforms. The recognition under the International Environmental Scientists Award framework reflects the importance of interdisciplinary scientific advancement, regulatory awareness, and evidence-driven healthcare research. Indexed citation metrics and author profiling databases indicate sustained academic engagement and measurable research visibility within the broader scientific community.[1][2]

Keywords

Research Excellence Award, Pharmacology, Saudi Food and Drug Authority, Scientific Recognition, Academic Research, Healthcare Sciences, Scopus Indexed Research, Evidence-Based Medicine, Scientific Publications, International Environmental Scientists Award

Introduction

The advancement of pharmacological and healthcare sciences relies on systematic investigation, scientific transparency, and evidence-based methodologies. Academic recognition programs such as the Research Excellence Award are designed to acknowledge researchers who demonstrate scholarly productivity, scientific integrity, and measurable contributions to their disciplines. Haya Alzeerโ€™s academic profile reflects participation in internationally indexed research activities and alignment with contemporary healthcare research standards.[1]

The Saudi Food and Drug Authority plays an important role in supporting scientific evaluation, healthcare safety, and regulatory research initiatives in Saudi Arabia. Researchers affiliated with such institutions contribute to the development of pharmacological assessments, public health monitoring, and analytical investigations relevant to healthcare systems and scientific governance.[3]

Research Profile

Haya Alzeer maintains a recognized academic presence through indexed scholarly databases and professional research identifiers. Her Scopus author profile documents research publications, citation records, and subject-area classification associated with pharmacology and healthcare sciences. The availability of an ORCID identifier further supports research transparency and author identity verification across international publishing systems.[1][4]

Research Contributions

The research contributions associated with Haya Alzeer involve participation in scientific studies relevant to healthcare assessment, pharmacological investigation, and evidence-based analytical practices. Such contributions support broader scientific objectives related to medication evaluation, healthcare quality assurance, and scientific data interpretation. The integration of indexed research findings into academic literature contributes to the advancement of reproducible scientific methodologies and interdisciplinary collaboration.[1]

Contemporary pharmacological research requires rigorous analytical standards, peer-review validation, and adherence to international publication ethics. Researchers operating within regulatory and healthcare institutions frequently contribute to the evaluation of safety frameworks, healthcare monitoring systems, and scientific reporting standards. These activities strengthen scientific reliability and public trust within healthcare-oriented research environments.[3]

Publications

Selected scholarly publications and indexed research records associated with Haya Alzeer demonstrate engagement with scientific publishing standards and peer-reviewed dissemination channels.[1]

Research Impact

Research impact may be evaluated through indexed citations, scholarly visibility, publication quality, and engagement with evidence-based scientific practices. Citation metrics associated with Haya Alzeerโ€™s academic profile demonstrate that her published work has contributed to ongoing scholarly discussions within healthcare and pharmacological sciences.[1]

The broader significance of scientific contributions in pharmacology extends beyond publication metrics to include support for healthcare evaluation, regulatory science, and public health awareness. Research dissemination through internationally indexed databases facilitates collaboration, reproducibility, and long-term scientific accessibility.[2]

Award Suitability

Haya Alzeerโ€™s scholarly profile demonstrates alignment with the objectives commonly associated with the Research Excellence Award. Her indexed publication record, citation performance, institutional affiliation, and scientific engagement collectively support recognition within an international academic award framework. Participation in peer-reviewed scientific activities and the maintenance of professional research identifiers further indicate commitment to research integrity and scholarly visibility.[1][4]

The International Environmental Scientists Award promotes interdisciplinary scientific recognition and encourages continued advancement in research quality, analytical rigor, and academic collaboration. Contributions connected to healthcare sciences and pharmacology remain essential to the development of evidence-based scientific systems and public health-oriented innovation.[6]

Conclusion

The Research Excellence Award article on Haya Alzeer presents a structured overview of her academic profile, institutional affiliation, indexed publication record, and measurable scholarly visibility within pharmacology and healthcare sciences. Through participation in peer-reviewed scientific activities and internationally recognized indexing systems, her work contributes to ongoing academic and healthcare-related research discussions. The documented research metrics and professional affiliations support recognition within a global scientific and academic context.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Haya Alzeer, Author ID 57202029321. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57202029321
  2. ORCID. (n.d.). ORCID record for Haya Alzeer.https://orcid.org/0009-0001-2301-4793
  3. Saudi Food and Drug Authority. (n.d.). Scientific and regulatory activities in healthcare and pharmacology.https://www.sfda.gov.sa/en
  4. Haak, L. L., Fenner, M., Paglione, L., Pentz, E., & Ratner, H. (2012). ORCID: a system to uniquely identify researchers. Learned Publishing, 25(4), 259โ€“264.https://doi.org/10.1087/20120404
  5. Alzeer, H., et al. (2023). Development and validation of a simple method for the determination of triamcinolone acetonide in nasal spray. Saudi Pharmaceutical Journal. https://pubmed.ncbi.nlm.nih.gov/37791036/

Joaquรญn Marรญa Campos Rosa | Pharmacology | Outstanding Scientist Award

Prof. Joaquรญn Marรญa Campos Rosa | Pharmacology | Outstanding Scientist Award

Professor Emeritus of the University of Granada | The University of Granada University | Spain

Prof. Joaquรญn Marรญa Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistryย  has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design.

ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  Citation Metrics ( Scopus )

4500

3750

3000

2250

1500

750

0

 

Citations
3894
h-index
34
i10-index
92

Citations

Documents

h-index

 

Faiz Ullah Khan | Pharmacology | Outstanding Contribution Award

Dr. Faiz Ullah Khan | Pharmacology | Outstanding Contribution Award

Dr. Faiz Ullah Khan | Pharmacology | Post-Doctoral Fellow at Peking University | Pakistan

Dr. Faiz Ullah Khan is a distinguished researcher and academic in the field of pharmacy and pharmaceutical sciences, currently affiliated with Peking University, where he has made significant contributions to clinical pharmacy, public health, and pharmacovigilance. Dr. Faiz Ullah Khan earned his PhD, MPhil, and PharmD degrees, equipping him with a robust educational foundation in clinical research, drug safety, and evidence-based pharmacy practice. Professionally, Dr. Faiz Ullah Khan has collaborated extensively with leading researchers and institutions globally, including Quaid-i-Azam University, Xiโ€™an Jiaotong University, Prince of Songkla University, Jouf University, and the RCSI School of Pharmacy and Biomolecular Sciences, contributing to numerous international research projects in medication safety, antibiotic stewardship, and disease burden assessments.

Citation Metrics (Google Scholar)

2000

1600

1200

800

400

0

.

Citations
1659
i10index
45

h-index
23

๐ŸŸฆ Citationsย  ย  ๐ŸŸฅ i10indexย  ย ๐ŸŸฉ h-index

View Google Scholar Profile

Featured Publications:

Clinical Case Studies on Medication Safety

โ€“ Elsevier, 2023 ยท 245 Citations
Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023

โ€“ Journal of the American College of Cardiology, 2025 ยท 64 Citations
Knowledge, Attitude, and Practices (KAPs) of Community Pharmacists Regarding COVID-19: A Cross-Sectional Survey in 2 Provinces of Pakistan

โ€“ Disaster Medicine and Public Health Preparedness, 2022 ยท 60 Citations
Global, Regional, and National Trends in Routine Childhood Vaccination Coverage from 1980 to 2023 with Forecasts to 2030: A Systematic Analysis for the Global Burden of Disease

โ€“ The Lancet, 2025 ยท 58 Citations
Knowledge, Attitude and Practices Among Consumers Toward Antibiotics Use and Antibiotic Resistance in Swat, Khyber-Pakhtunkhwa, Pakistan

โ€“ Expert Review of Anti-Infective Therapy, 2020 ยท 58 Citations

 

Prof Dr. Claudio Bucolo | Pharmacology | Best Researcher Award

Prof Dr. Claudio Bucolo | Pharmacology | Best Researcher Award

Prof Dr. Claudio Bucolo, University of Catania, Italy

Prof. Claudio Bucolo is a distinguished Full Professor of Pharmacology at the University of Catania. With a profound commitment to pharmacological research, particularly in the field of ophthalmology, Prof. Bucolo has garnered international recognition for his groundbreaking work. He has served as a Visiting Scholar at the Eye Research Institute, Oakland University, USA, and has received prestigious awards for his contributions to ocular pharmacology. He has authored over 225 scientific papers, filed 11 international patents, and continues to shape the scientific community with his leadership roles.

profile

Orcid

Strengths for the Award

Prof. Claudio Bucolo stands out as a strong candidate for the Best Researcher Award or Outstanding Scientist Award due to his remarkable achievements in the field of ocular pharmacology and neuropharmacology. He has received multiple prestigious international awards, such as the Dr. Roger Vogel Award and the Gold Fellow Medal for his contributions to ophthalmic disease treatments. With over 225 peer-reviewed publications, 11 international patents, and 8210 citations, his research has made a substantial impact. Additionally, his leadership roles in global conferences (ARVO) and editorial boards demonstrate his academic influence and dedication.

Areas for Improvement

While Prof. Bucolo’s expertise and leadership in ocular pharmacology are well-established, expanding his research focus to other domains of pharmacological research may increase his versatility and influence across broader scientific fields. Collaborating with more interdisciplinary teams could also enhance the global reach of his work. Furthermore, fostering young researchers through mentorship and expanding his role in educational initiatives can further strengthen his candidacy for future honors.

Education ๐ŸŽ“

Prof. Bucolo holds a comprehensive background in pharmacology, with advanced academic training and teaching roles at the University of Catania. His extensive experience as a Visiting Scholar at the Eye Research Institute, Oakland University (USA), has enriched his research perspectives and solidified his expertise in pharmacology applied to ophthalmology.

Experience ๐Ÿง‘โ€๐Ÿซ

Prof. Bucolo has had an illustrious career in academia and pharmacological research, holding key leadership positions at international conferences and organizations. He has served twice as President of the Pharmacology Section for the ARVO Conference Organizing Committee and as a board trustee for the Association for Ocular Pharmacology and Therapeutics. Additionally, he is Deputy Rector for Education in PhD Programs at the University of Catania and Director of the Research Center in Ocular Pharmacology (CERFO).

Research Interest ๐Ÿ”ฌ

Prof. Bucolo’s primary research focuses on ocular pharmacology and neuropharmacology, investigating new drug therapies for ophthalmic diseases. His work contributes to understanding the pharmacodynamics and pharmacokinetics of novel treatments for vision-related disorders. He has made significant strides in neuroprotective strategies and drug delivery systems for ocular health.

Awards ๐Ÿ†

Prof. Bucolo has received numerous accolades for his contributions to pharmacology and ophthalmology. Notable honors include the “Dr. Roger Vogel Award for Pharmaceutical Research” in 2015, the “Silver Fellow Medal” from the Association for Research in Vision and Ophthalmology (ARVO) in 2014, and the prestigious “Gold Fellow Medal” in 2019 for his outstanding service to the vision community. In 2019, he was also awarded the “Chancellor’s Award Guest” from Louisiana State University for his exceptional contributions to ophthalmic pharmacology.

Publication Top notes ๐Ÿ“š

Bucolo C., et al. (2023). “Novel ocular drug delivery systems.” Journal of Ocular Pharmacology and Therapeutics. Cited by 50 articles. Link

Bucolo C., et al. (2022). “Neuroprotective agents in ophthalmology.” Experimental Eye Research. Cited by 40 articles. Link

Bucolo C., et al. (2020). “Advances in pharmacology for retinal diseases.” International Journal of Molecular Sciences. Cited by 65 articles. Link

Conclusion

Prof. Claudio Bucolo is a highly deserving candidate for both the Best Researcher Award and the Outstanding Scientist Award. His groundbreaking contributions to pharmacology, strong publication record, and international recognition solidify his reputation as a leading scientist in ophthalmic research. With a few strategic enhancements in interdisciplinary work and mentorship, his legacy in science could be even more profound.

Assist Prof. Dr. Tanya Ralli | Pharmacology | Young Scientist Award

Assist Prof. Dr. Tanya Ralli | Pharmacology | Young Scientist Award

Assist Prof. Dr.Tanya Ralli, COER University, Roorkee, India

Assistant Professor Dr. Tanya Ralli, based at COER University in Roorkee, India, is a distinguished figure in pharmacology. Her expertise spans innovative research in pharmaceutical sciences, focusing on groundbreaking advancements. Dr. Ralli’s commitment to academia and her role as a mentor inspire the next generation of scientists. She is renowned for her contributions to pharmacological studies, particularly in areas like drug development and therapeutic interventions. Awarded the prestigious Young Scientist Award, Dr. Ralli continues to drive impactful research that shapes the future of pharmacology. ๐ŸŒŸ๐Ÿ”ฌ

PROFILE

Scopus

ACADEMIC BACKGROUND

Dr. Tanya Ralli is currently serving as an Assistant Professor at COER University, Roorkee, since January 2024. She completed her Ph.D. in Pharmaceutics from Jamia Hamdard, New Delhi, in December 2023. Her academic journey includes an M.S. in Pharmaceutics from NIPER, S.A.S Nagar, with a remarkable 9.92 CGPA and a Bachelor of Pharmacy from DIPSAR, Delhi. Dr. Ralli has also pursued advanced diplomas in Patent Law from NALSAR, Hyderabad, and Regulatory Affairs from Jamia Hamdard. Her educational foundation started with excellence in Senior and Secondary School from Kulachi Hansraj Model School. ๐ŸŽ“

RESEARCH PROJECT

๐ŸŽ“ Assist. Prof. Dr. Tanya Ralli completed her Ph.D. at Jamia Hamdard under the guidance of Prof. Kanchan Kohli and Prof. Vidhu Aeri. Her research focused on the development of formulations containing bacteria and herbal drugs for the treatment of NAFLD (Non-Alcoholic Fatty Liver Disease). Earlier, she pursued her M.S. (Pharm) project titled “To study the crystallization tendency of ASDs and validate its correlation with Isobaric Fragility and Alpha relaxation stretch parameter,” supervised by Prof. Arvind Kumar Bansal. Dr. Ralli’s academic journey reflects her commitment to pharmaceutical research and innovative healthcare solutions.

AWARDS AND HONOR

๐Ÿ† Dr. Tanya Ralli has garnered notable recognition throughout her academic and professional journey. She achieved the prestigious Best E Abstract Award at the NIPER-Hyderabad online conference in 2020, showcasing her research prowess. Her academic excellence was highlighted by receiving a Gold Medal as the University Topper during her M.S. (Pharm.) at NIPER. She was honored by MHRD for being among India’s top 100 students and by the Delhi Pharmacy Council for securing the 2nd position in B.Pharm. Dr. Ralli’s dedication to volunteerism was acknowledged with the Best Volunteer Award at the IPC in 2013. ๐ŸŒŸ

PROFESSIONAL SKILLS

๐Ÿ”ฌ Assist Prof. Dr. Tanya Ralli brings a wealth of technical expertise to her research endeavors. Her skills include operating advanced instruments such as High Performance Liquid Chromatography (HPLC), UV spectrophotometer, and IR spectroscopy. She specializes in isolating herbal compounds using preparative HPLC and High Performance Thin Layer Chromatography (HPTLC), alongside techniques like Differential Scanning Calorimeter (DSC) and Dielectric Spectroscopy (DES). Proficient in MS Office, ChemDraw, and data analysis tools like SPSS and Python, she excels in molecular docking analysis and bioinformatics. Her ability to retrieve data from scientific databases and her aptitude in report drafting underscore her multidisciplinary approach.

KEY ACHIEVEMENTS

Dr. Tanya Ralli is a distinguished academician and researcher, renowned for her achievements in pharmaceutical sciences. She clinched the Best e-Abstract Award at NIPER-Hyderabad’s 2020 online conference and was honored with a Certificate of Distinction at the GO4youth Olympiad by TERI in 2019-2020. Her academic prowess shone through as she secured the University Topper title and a Gold Medal in M.S. (Pharm.). Dr. Ralli’s excellence was recognized nationally when she was felicitated by MHRD for ranking among India’s top 100 students. Her journey also includes accolades from Delhi Pharmacy Council and IPC for her outstanding academic and volunteer contributions. ๐Ÿ…

WORPSHOPS ATTENDED

Dr. Tanya Ralli is a dedicated academic with a passion for continuous learning and professional development. She has actively participated in several prestigious workshops and conferences to enhance her expertise. Notably, she attended the international workshop on Quality by Design in December 2022, and earlier, engaged in workshops like PUMAS in February 2020 and Bio-Statistical Analysis on SPSS & Research Paper Writing in December 2019. Her training extends to practical skills such as HPLC through sessions by Jamia Hamdard and Shimadzu in September 2019. Dr. Ralli also contributed to the field of phytopharmaceuticals at the IPC’s residential course in 2019. Her commitment to knowledge includes participation in conferences like the 6th International Conference on Cardiovascular Sciences in 2014 and volunteering at the 65th Indian Pharmaceutical Congress in 2013. ๐ŸŽ“

EXPERIENCE

Dr. Tanya Ralli has a diverse academic and professional background. She has contributed significantly to academia, teaching B. Pharm and D. Pharm classes at Jamia Hamdard for 2 years, from 2021 to 2023. Her passion for education extended beyond formal settings, with 6 months of voluntary teaching at the NGO “Umeed: A drop of hope” in 2021. Dr. Ralli enhanced her skills through intensive training in bioinformatics, R programming, Python, and Next Generation Sequencing at Eminent Biosciences. Additionally, she gained expertise in HPLC and HPTLC during a 3-month training at the Indian Pharmacopoeia Commission for her PhD. Her career also includes part-time teaching at ASS Science Foundation and a role as a trainee analyst at WNS Global Services. ๐Ÿ“š

Publication Top Notes

Exploring the therapeutic potential of silymarin-based herbal remedy (prebiotic) and probiotic blend in a mouse model of NAFLD: Insights into gut microbiota modulation and liver health

Hypothesizing the Green Synthesis of Tamoxifen Loaded Magnetic Nanoparticles for the Treatment of Breast Cancer

Cannabis sativa in Phytotherapy: Reappraisal of Therapeutic Potential and Regulatory Aspects

BBD Driven Fabrication of Hydroxyapatite Engineered Risedronate Loaded Thiolated Chitosan Nanoparticles and Their In Silico, In Vitro, and Ex Vivo Studies